Study Details
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Clinicaltrials.gov ID
Astellas Study ID
9785-CL-0123
EudraCT ID
2016-001694-32
Condition
Prostate Cancer
Phase
Phase 2
Age
18 Years - N/A
Sex
Male
Product
enzalutamide
Type
Interventional
Trial Dates
Dec 2016 - Sep 2025
Masking
None (Open Label)
Enrollment number
900
A Phase 2 Open-label Extension Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Study summary
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Site GB44005
Cardiff, United Kingdom, CF4 4XN
Site PL48004
Pozman, Poland
Site DK45004
Herlev, Denmark, 2730
Site US10059
New York, United States, 10065
Site CL56004
IX Region, Chile
Site PL48001
Myslowice, Poland
Site US10017
Denver, United States, 80211
Site US10011
Tucson, United States, 85741
Site US10021
Madison, United States, 53792
Site US10004
Hackensack, United States, 07601
Site US10032
St. Louis, United States, 63110
Site US10018
Charleston, United States, 29414
Site KR82005
Seongnam-si, Republic of Korea
Site GB44003
Belfast, United Kingdom
Site BE32003
Turnhout, Belgium, 2300
Site DE49004
Nürtingen, Germany, 72622
Site US10031
Greensboro, United States, 27403
Site CA15003
Kingston, Canada, K7L 3J7
Site US10003
Myrtle Beach, United States, 29572
Site KR82003
Seoul, Republic of Korea
Site DE49007
Waldshut-Tiengen, Germany, 79761
Site AU61006
Ashford, Australia
Site SE46003
Umeå, Sweden, 90185
Site FR33006
Nimes, France, 30029
Site IL97202
Peth Tikva, Israel
Site IL97204
Ramat-Gan, Israel
Site US10055
New York, United States, 10065
Site GB44007
Manchester, United Kingdom, M20 4BX
Site GB44002
Glasgow, United Kingdom
Site KR82001
Seoul, Republic of Korea
Site US10020
Concord, United States, 28025
Site FR33010
Lille, France, 59037
Site AU61004
Westmead, Australia
Site US10038
Seattle, United States, 98109
Site US10027
Lancaster, United States, 17604
Site FR33002
Lyon Cedex 3, France, 69003
Site CL56002
Santiago, Chile
Site US10024
Garden City, United States, 11530
Site US10043
Houston, United States, 77030
Site GB44009
Bebington, United Kingdom
Site IT39002
Forli, Italy
Site DE49003
Hamburg, Germany, 22081
Site DE49001
Duisburg, Germany, 47179
Site KR82004
Seoul, Republic of Korea
Site US10008
San Bernardino, United States, 92404
Site US10042
San Diego, United States, 92108
Site US10050
Washington, United States, 20037
Site CA15001
Granby, Canada, J2G 8Z9
Site ES34001
Madrid, Spain, 28034
Site ZA27001
George, South Africa, 6529
Site US10049
Daytona Beach, United States, 32114
Site CL56001
Vina del Mar, Chile
Site SE46001
Göteborg, Sweden, 41345
Site CZ42003
Praha 2, Czech Republic
Site PL48003
Wroclaw, Poland
Site US10041
Nashville, United States, 37232-2765
Site AR54003
Cordorba, Argentina
Site US10010
Dallas, United States, 75231
Site FR33008
La Roche sur Yon, France, 85925
Site DE49013
Hamburg, Germany
Site CZ42002
Olomouc, Czech Republic, 779 00
Site KR82002
Seoul, Republic of Korea
Site GB44006
London, United Kingdom
Site US10034
Houston, United States, 77024
Site BE32007
Hasselt, Belgium
Site GB44004
Bristol, United Kingdom, BS28HW
Site FR33017
Paris, France
Site AU61009
Malvern, Australia
Site ES34004
Barcelona, Spain
Site AU61001
Tweed Heads, Australia, 2485
Site CA15011
Montreal, Canada
Site IT39001
Arezzo, Italy
Site BE32002
Kortrijk, Belgium, 8500
Site US10022
Springfield, United States, 97477
Site DK45003
Aarhus, Denmark, 8200
Site US10023
Omaha, United States, 68130
Site FR33003
Paris, France
Site GB44008
Northwood, United Kingdom
Site US10053
Syracuse, United States, 13210
Site GB44001
Sutton, United Kingdom
Site BE32001
Liege, Belgium, 4000
Site FL35802
Tampere, Finland
Site DE49010
Bonn, Germany, 53111
Site US10046
Winston-Salem, United States, 27157
Site US10002
Chicago, United States, 60637
Site US10062
Charlotte, United States, 28207
Site US10048
Jacksonville, United States, 32216
Site RU70001
Moscow, Russian Federation
Site SK10223
Bratislava, Slovakia
Site US10052
Anchorage, United States, 99503
Site US10035
Cincinnati, United States, 45212
Site US10005
Pittsburgh, United States, 15232
Site ES34005
Pamplona, Spain
Site US10009
Los Angeles, United States, 90048
Site BE32005
Gent, Belgium, 9000
Site GE99501
Tbilisi, Georgia, GE- 0186
Site IT39005
Roma, Italy
Site CZ42001
Praha 6, Czech Republic, 16000
Site PL48002
Gdansk, Poland
Site NZ64001
Hamilton, New Zealand
Site MD37301
Chisinau, Republic of Moldova
Site ES34003
Barcelona, Spain
Site DK45001
Copenhagen, Denmark, 2100
Site US10015
Virginia Beach, United States, 23462
Site US10001
Aurora, United States, 80045
Site FR33001
Saint Herblain, France
Site AU61008
South Brisbane, Australia
Site US10029
Towson, United States, 21204
Site AR54002
Tucuman, Argentina
Site RU70003
St. Petersburg, Russian Federation
Site US10007
Jeffersonville, United States, 47130
Site FR33004
Villejuif, France
Site DK45002
Aalborg, Denmark, 9000
Site US10030
Chapel Hill, United States, 27599
Site IT39004
Cremona, Italy
Site IL97203
Tzrifin Beer Yakov, Israel
Site US10040
Los Angeles, United States, 90024
Site US10028
Stanford, United States, 94305
Site BE32008
Leuven, Belgium, 3000
Site US10014
Norfolk, United States, 23502
Site BE32004
Brussels, Belgium, B-1090
Site DE49006
Mannheim, Germany, 68167
Site FR33019
Strasbourg, France, 67000
Site AR54005
Buenos Aires, Argentina, C1120AAT
Site BE32011
Gent, Belgium, 9000
Site SK42105
Nitra, Slovakia, 949 01
Site AU61004
Westmead, Australia, 2145
Site US10066
Lenexa, United States, 66214-1656
Site TW88602
Taichung, Taiwan, Province of China, 40447
Site FR33020
Montpellier Cedex, France, 34298
Site AU61014
Albury, Australia, 2640
Site TW88603
Kaohsiung, Taiwan, Province of China, 81362
Site KR82007
Seoul, Republic of Korea, 06351
Site FR33022
Strasbourg, France, 67098
Site TH66001
Hat Yai, Thailand, 90110
Site IT39008
Faenza (RA), Italy, 48018
Site SK42106
Kosice, Slovakia, 04191
Site AU61017
Wahroonga, Australia, 2076
Site TH66002
Bangkok, Thailand, 10330
Site PL48005
Slupsk, Poland, 76-200
Site NL31004
Maastricht, Netherlands, 6229
Site ES34011
Gerona, Spain, 17007
Site ES34007
Barcelona, Spain, 08036
Site ES34012
Madrid, Spain, 28006
Gunma University Hospital
Maebashi-shi, Japan
The Cancer Institute Hospital of Japanese Foundation for Cancer Research
Koutou-ku, Japan
Toho University Sakura Medical Center
Sakura-shi, Japan
Site US10067
Orange, United States, 92868
Chiba cancer center
Chiba, Japan, 260-8717
Harasanshin hospital
Fukuoka, Japan, 812-0033
Kyoto University hospital
Kyoto, Japan, 606-8507
Kindai University Hospital
Sayama, Japan, 589-8511
Yokohama City University Medical Center
Yokohama, Japan, 232-0024
Niigata University Medical and Dental Hospital
Niigata, Japan, 951-8520
Site TW88601
Kaohsiung, Taiwan, Province of China
Site HK85202
Hong Kong, Hong Kong
Site KR82011
Seoul, Republic of Korea, 138-736
Hudson Valley Urology, PC
Poughkeepsie, United States, 12601
Site IT39006
Trento, Italy, 38122
Site BR55004
Ijuí, Brazil, 98700-000
Site TW88606
Taipei, Taiwan, Province of China, 10002
Nippon Medical School Hospital
Bunkyo-ku, Japan
Kyushu University Hospital
Higashi-ku, Japan
The purpose of this website is to offer education and information to patients and their families and friends, the public, and healthcare professionals about the clinical trial process. In addition, the website will provide specific information about Astellas clinical trials. Please read the complete Astellas Transparency Policy to learn about the clinical trial information available on this website
© ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.
POWERED BY:
